2019
DOI: 10.1080/1061186x.2019.1703189
|View full text |Cite
|
Sign up to set email alerts
|

Pyrrole derivatives as potential anti-cancer therapeutics: synthesis, mechanisms of action, safety

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
14
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 25 publications
(20 citation statements)
references
References 89 publications
2
14
0
Order By: Relevance
“…Spectroscopic data agree with those published [30]. (15). Acetonitrile (24 mL) was added to a mixture of 14 (1.64 mmol), pyrrole (8.2 mmol), potassium iodide (1.97 mmol), copper powder (1.64 mmol), and cesium carbonate (3.28 mmol).…”
Section: Synthesis Of 2-bromo-4-isopropyl-1-nitrobenzene (14)supporting
confidence: 82%
See 1 more Smart Citation
“…Spectroscopic data agree with those published [30]. (15). Acetonitrile (24 mL) was added to a mixture of 14 (1.64 mmol), pyrrole (8.2 mmol), potassium iodide (1.97 mmol), copper powder (1.64 mmol), and cesium carbonate (3.28 mmol).…”
Section: Synthesis Of 2-bromo-4-isopropyl-1-nitrobenzene (14)supporting
confidence: 82%
“…Pyrrole derivatives are privileged structures in medicinal chemistry due to the uncountable pharmacological profiles [14]. Among the activities, the anticancer one has been described for different types of pyrrole derivatives [14,15].…”
Section: Introductionmentioning
confidence: 99%
“…These compounds induce apoptosis in colorectal cancer cells. Thus, these compounds could be used as inhibitors of EGFR and VEGFR, which may promote the realization of their pro-apoptotic and anti-cancer activities (Kuznietsova et al, 2020). In addition, another study found that pyrrole derivatives JG-03-14 showed reported anti-proliferative activity in MCF-7/caspase-3 cells and the MCF-7/ADR (multidrug-resistant) cell line.…”
Section: Discussionmentioning
confidence: 99%
“…So, VEGF and EGFR inhibitors constitute therapies that inhibit different signaling pathways to overcome tumor resistance caused by the inhibition of a single. Because of this, Kuznietsova et al [ 118 ] reported the synthesis of novel pyrrole analogs as protein kinases inhibitors. Their investigation suggested that two compounds, namely chloro-1-(4-chlorobenzyl)-4-((3-(trifluoromethyl)phenyl)amino)-1H-pyrrole-2,5-dione (36 a) and 5-amino-4-(1,3-benzothyazol-2-yn)-1-(3-methoxyphenyl)-1,2-dihydro-3H-pyrrole-3-one (36 b), are the competitive inhibitors of EGFR and VEGFR (Fig.…”
Section: Anticancer Agentsmentioning
confidence: 99%